arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Opko Health, Inc.

OPK Health Care Biotechnology: Pharmaceutical Preparations
$1.64
▲ +2.2% Today
as of Oct 23, 13:05 ET
Last 30 days +4.81% Sep 14 → Oct 23
$1.29 $1.41 $1.53 $1.64 $1.76 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.60
High
$1.67
Low
$1.58
Volume
$2M
Avg Vol
$3M
Mkt Cap
$1.0B
P/E (TTM)
—
Beta
—
52w High
$1.77
52w Low
$0.98
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 15 items

Oct 17 · 18:14 Simply Wall St.
OPKO Health (OPK) Sells BioReference Assets On A Valuation Story That Still Divides
Oct 17 · 13:16 Simply Wall St.
Is OPKO Health (OPK) Pricing In Too Much For Sales?
Oct 16 · 14:20 Zacks
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
▸ Show all 15 press releases & news Free account →

OPK earnings at a glance

Opko Health, Inc. (OPK) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of -$0.07, compared with $0.03 in the same quarter last year (-333%). The options market is pricing a move of about ±21.9% after the report, a range of roughly $1.28 to $2.00 from today's $1.64. Over its last 6 reports the stock rose the next day 2 times and fell 4, moving ±8.8% on average; after the most recent report on Jul 27, 2026 it moved +33.1%. That means options currently expect more movement than OPK has typically delivered. OPK beat the consensus EPS estimate in 3 of its last 6 reported quarters. Implied volatility is currently 186%. The share price of $1.64 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.98
$1.77
84% of range
Avg surprise (last 6)
+42.6%
Avg reaction (last 6)
+2.9%
33% positive
Latest IV / EM
186%
EM ±21.9% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.19$-0.14$-0.08$-0.02$0.03 Actual $-0.02Actual $-0.11Actual $-0.10Est $-0.06Actual $-0.19Est $-0.12Actual $0.03Est $-0.02Actual $-0.04Est $-0.07Actual $-0.07Est $-0.07Actual $-0.01Est $-0.08 MarSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$-148M$-68M$12M$92M$172M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon Jul 27, 2026Jun/2026 $-0.01 $-0.08 +87.5% +57.9% +33.1% earnings
Tue Apr 28, 20268K 2026-04-28 $-0.07 $-0.07 0.0% — -8.3% earnings
Thu Feb 26, 20268K 2026-02-26 $-0.04 $-0.07 +42.9% — 0.0% earnings
Wed Oct 29, 2025Sep/2025 $0.03 $-0.02 +250.0% — +2.1% earnings
Thu Jul 31, 2025Jun/2025 $-0.19 $-0.12 -58.3% — -7.0% earnings
Wed Apr 30, 2025Mar/2025 $-0.10 $-0.06 -66.7% — -2.2% earnings
Sat Sep 30, 2023Sep 2023 $-0.11 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.02 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER -$0.07$0.03 -333.3%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$164M$124M——$157M$150M——
Cost of revenue$84M$78M—$102M$107M$107M—$134M
Gross profit$80M$46M—$50M$49M$43M—$40M
Operating income$-7M$-51M—$48M$-60M$-67M—$-67M
Net income$-8M$-55M——$-148M$-68M——
EPS (diluted)$-0.01$-0.07——$-0.19$-0.10——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$301M$332M$364M$412M$267M$429M$427M$400M
Inventory$62M$64M$66M$65M$66M$64M$57M$59M
Total current assets$500M$535M$582M$627M$583M$738M$662M$630M
Total assets$1.83B$1.86B$1.93B$2.00B$1.97B$2.13B$2.20B$2.26B
Long-term debt$2M$2M$2M$3M$3M$3M$3M$4M
Total liabilities$645M$652M$664M$690M$676M$817M$835M$853M
Total equity$1.18B$1.20B$1.27B$1.31B$1.30B$1.31B$1.37B$1.40B

Implied volatility — last 90 days

49%134%219%304%389% Jun 07 — IV 201% · EM ±27.8%Jun 08 — IV 167% · EM ±22.1%Jun 09 — IV 283% · EM ±35.5%Jun 10 — IV 235% · EM ±27.8%Jun 12 — IV 279% · EM ±28.6%Jun 15 — IV 389% · EM ±28.2%Jun 25 — IV 51% · EM ±10.0%Jun 26 — IV 69% · EM ±13.2%Jun 30 — IV 136% · EM ±23.3%Jul 02 — IV 102% · EM ±16.4%Jul 03 — IV 105% · EM ±16.4%Jul 08 — IV 113% · EM ±14.2%Jul 21 — IV 249% · EM ±57.9%Jul 22 — IV 253% · EM ±57.9%Jul 24 — IV 223% · EM ±49.2%Jul 28 — IV 82% · EM ±16.8%Jul 29 — IV 92% · EM ±18.4%Jul 30 — IV 115% · EM ±22.5%Jul 31 — IV 158% · EM ±30.3%Aug 03 — IV 129% · EM ±22.9%Aug 04 — IV 223% · EM ±38.5%Aug 05 — IV 113% · EM ±18.8%Aug 06 — IV 164% · EM ±26.5%Aug 17 — IV 308% · EM ±25.7%Aug 18 — IV 256% · EM ±18.5%Aug 19 — IV 314% · EM ±18.5%Aug 25 — IV 50% · EM ±10.1%Aug 26 — IV 50% · EM ±9.9%Aug 27 — IV 51% · EM ±9.9%Aug 28 — IV 53% · EM ±10.2%Sep 02 — IV 143% · EM ±24.0%Sep 03 — IV 96% · EM ±15.5%Sep 04 — IV 98% · EM ±15.2%Sep 07 — IV 110% · EM ±15.2%Sep 11 — IV 145% · EM ±16.0%Sep 14 — IV 115% · EM ±9.6%Sep 16 — IV 268% · EM ±15.8%Sep 17 — IV 301% · EM ±12.6%Sep 22 — IV 187% · EM ±38.2%Sep 23 — IV 132% · EM ±26.5%Sep 25 — IV 159% · EM ±30.5%Oct 01 — IV 79% · EM ±12.8%Oct 02 — IV 164% · EM ±25.6%Oct 08 — IV 186% · EM ±21.9%

Sector peers

PCRX
Pacira BioSciences, Inc.
$1.0B $36.36+0.1%
JANX
Janux Therapeutics, Inc.
$1.1B $16.68-1.5%
MNKD
MannKind Corporation
$1.1B $3.15+3.3%
KURA
Kura Oncology, Inc.
$949M $9.59-2.9%
MLTX
MoonLake Immunotherapeutics
$917M $11.53+8.3%
ABUS
Arbutus Biopharma Corporation
$902M $4.20+0.5%

OPK earnings FAQ

When is OPK's next earnings date?

Opko Health, Inc. is expected to report on November 4, 2026.

What is OPK's expected move for earnings?

Options currently price a move of about ±21.9%, or $0.36 per share either way from $1.64.

How does OPK stock usually react to earnings?

Across the last 6 reports the average next-day move was ±8.8%, up 2 times and down 4 times.

What EPS are analysts expecting from Opko Health, Inc.?

The consensus estimate is -$0.07 per share, versus $0.03 a year ago.

What is OPK's implied volatility?

OPK's at-the-money implied volatility is about 186% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in